Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?

Publisher： Elsevier

ISSN： 0022-510X

Source： Journal of the Neurological Sciences, Vol.217, Iss.2, 2004-02, pp. : 123-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The effect of prednisone on the progression from ocular to generalized myasthenia gravis

By Monsul N.T. Patwa H.S. Knorr A.M. Lesser R.L. Goldstein J.M.

Journal of the Neurological Sciences, Vol. 217, Iss. 2, 2004-02 ,pp. : 131-133

Elsevier

Access to resources Recommend Favorite

Advances in the treatment of myasthenia gravis

By Gilhus Nils Erik

Future Neurology, Vol. 7, Iss. 6, 2012-11 ,pp. : 701-708

Future Medicine

Access to resources Recommend Favorite

Thymectomy: role in the treatment of myasthenia gravis

By Spillane J. Hayward M. Hirsch N. Taylor C. Kullmann D. Howard R.

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1798-1801

Springer Publishing Company

Access to resources Recommend Favorite

myasthenia gravis

PRACTICAL NEUROLOGY, Vol. 3, Iss. 3, 2003-06 ,pp. : 184-185

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis

By Evoli A.

Brain, Vol. 126, Iss. 10, 2003-10 ,pp. : 2304-2311

Oxford University Press

Access to resources Recommend Favorite